Adjuvant Chemotherapy for Locally Advanced Rectal Cancer: Is It a Given?
Massachusetts General Hospital and Harvard Medical School, Boston, MA tshong1@partners.org.
Theodore S
TS
Hong
Massachusetts General Hospital and Harvard Medical School, Boston, MA.
David P
DP
Ryan
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage / Q000627:therapeutic use*; D059186:Chemoradiotherapy, Adjuvant; D017024:Chemotherapy, Adjuvant; D018572:Disease-Free Survival; D004334:Drug Administration Schedule; D005060:Europe; D005472:Fluorouracil / Q000008:administration & dosage; D006801:Humans; D002955:Leucovorin / Q000008:administration & dosage; D020360:Neoadjuvant Therapy / Q000379:methods*; D009367:Neoplasm Staging; D009944:Organoplatinum Compounds / Q000008:administration & dosage; D010523:Peripheral Nervous System Diseases / Q000139:chemically induced; D016032:Randomized Controlled Trials as Topic; D012004:Rectal Neoplasms / Q000188:drug therapy* / Q000473:pathology / Q000601:surgery; D011984:Sensory Receptor Cells / Q000187:drug effects; D016896:Treatment Outcome; D014481:United States
D009944:Organoplatinum Compounds; D002955:Leucovorin; D005472:Fluorouracil